Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 GeneticVariation disease BEFREE CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. 23255553 2013
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 GeneticVariation disease BEFREE CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus. 21504716 2011
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 Biomarker disease BEFREE Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines. 21745168 2011
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 AlteredExpression disease BEFREE In mantle-cell lymphoma, the t(11;14) translocation leads to overexpression of cyclin-D1, in addition to which cyclin-D1-negative mantle-cell lymphoma that overexpress cyclin-D2 or D3 have also been described. 20062012 2010
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 GeneticVariation disease BEFREE We analyzed 4 cases of cycD2(+) mantle cell lymphoma with a translocation involving the CCND2 locus, and its differential diagnosis from 35 mature B-cell non-Hodgkin's lymphomas based on immunohistochemistry, quantitative RT-PCR and FISH analysis. 19608671 2009
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 AlteredExpression disease BEFREE Cyclin D2 and D3 mRNA levels were significantly higher in cyclin D1-negative mantle cell lymphoma than in conventional mantle cell lymphoma but the protein expression was not discriminative. 19880778 2009
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 AlteredExpression disease LHGDN Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. 18391076 2008
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse
0.080 Biomarker disease BEFREE Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. 18685613 2008